On April 1, it was reported that the announcement data showed that the ChinaAMC SSE Science and Technology Innovation Board Biomedical ETF (588130), a subsidiary of China AMC Fund, will be publicly offered from April 7, 2025 to April 11, 2025. The investment type of ChinaAMC SSE STAR Market Biomedical ETF is a replication index fund, with a management fee of 0.5% per annum and a custody fee of 0.1% per annum.
The investment objective of ChinaAMC SSE STAR Market Biomedical ETF is to closely track the underlying index and pursue tracking difference and tracking error minimization. The Fund strives to achieve an absolute TD of no more than 0.2% per day and an annual TD of no more than 2%.
The portfolio ratio of ChinaAMC SSE STAR Market Biomedical ETF is as follows: Normally, the Fund's portfolio ratio is as follows: the proportion of the Fund's investment in the underlying index constituent stocks and alternative constituent stocks is not less than 90% of the Fund's net asset value, and not less than 80% of the non-cash fund assets. At the end of each trading day, the Fund shall maintain cash at least one time of the trading margin after deducting the trading margin required for stock index futures, treasury bond futures and stock options contracts. Among them, cash does not include settlement reserves, deposit margins, subscription receivables, etc. If laws, regulations or regulatory authorities change the investment ratio limit of investment products, the fund manager may adjust the investment ratio of the above-mentioned investment products after performing appropriate procedures.
ChinaAMC SSE Science and Technology Innovation Board Biomedical ETF tracks Kechuang Biotech (000683), with a rolling P/E ratio of 37.39 times, which is at the 28.99% quantile since its launch; The price-to-book ratio is 5.87 times, which is at the 47.83% quantile since its release; The dividend yield is 0.91%. The maximum drawdown of Kechuang Biotech is 48.53%. The weights of the top 10 ingredients are as follows:
| code | abbreviation | stock price (yuan) | weight | Shenwan primary industry | Shenwan secondary industry |
|---|---|---|---|---|---|
| 688271 | United Imaging Healthcare | 124 | 9.23% | pharmaceutical biomedical | devices |
| 688235 | BeiGene | 249.52 | 7.18% | Pharmaceutical, Biochemical | ,Pharmaceutical |
| 688617 | Huitai Medical | , 412.1 | 5.45%, | Pharmaceutical, Biomedical | ,and Medical Devices |
| 688506 | Baili Tianheng | 243.36 | 4.89% | Pharmaceutical, Biochemical | |
| 688578 | Allist | , 88.5 | ,4.62%, | Pharmaceutical, Biochemical | ,|
| Pharmaceutical 688114 | MGI | 79.73 | 4.47% | Pharmaceutical and Biomedical | Devices |
| 688180 | Junshi Biosciences | 31.69 | 4.28% | Pharmaceutical and Biological | Products |
| 688266 | Zelgen Pharmaceuticals | 106.6 | 3.98% | Pharmaceutical, | Biochemical |
| , Pharmaceutical 688278 | Tebao Pharmaceuticals | 79.63 | ,3.54% | Pharmaceuticals and Biology | Biological products |
| 688050 | Aibo Medical | 102.29 | 3.28% | Pharmaceutical and biomedical | devices |
The proposed fund manager of ChinaAMC SSE Science and Technology Innovation Board Biomedical ETF is Lu Yayun. Lu Yayun, Master. He used to be a researcher of Guotai Fund and a marketing manager of Yinhua Fund. He joined China Asset Management in June 2020 and has served as a researcher and assistant fund manager in the quantitative investment department. He is currently the fund manager of a number of funds, including the ChinaAMC ChiNext Momentum Growth Exchange-traded Open-ended Index Securities Investment Fund Initiator Feeder Fund and the ChinaAMC CSI All-Index Securities Company Exchange-traded Open-ended Index Securities Investment Fund Initiator Feeder Fund, with a tenure ranging from June 2022 to October 2024.
Up to now, Lu Yayun has managed 18 funds, of which 6 funds have lost money during their tenure, with a maximum loss of 35.08%.
Since February 7, 2024, Lu Yayun has managed ChinaAMC CSI Hong Kong Stock Connect Central Enterprises Dividend ETF with a tenure return of 33.56%, an average of 24.61% for the same category, and an industry ranking of 816/3434. From the perspective of profit and loss, the profit during the tenure (2024) is 104 million yuan, and the management fee is 1.9039 million yuan.
Since June 10, 2022, Lu Yayun has managed the ChinaAMC ChiNext Momentum Growth ETF Initiation Connection A product, with a tenure return of -28.37%, an average of -3.96% for the same category, and an industry ranking of 2245/2549. From the perspective of profit and loss, the loss during the tenure (2022H2 - 2024H2) was 446 million yuan, and the management fee was 849,600 yuan.
Since June 10, 2022, Lu Yayun has managed the ChinaAMC CSI All-Index Securities Company ETF Connect A product, with a tenure return of 14.47%, and the average of the same category is -3.96%, ranking 414/2549 in the industry. From the perspective of profit and loss, the profit during the tenure (2022H2 - 2024H2) was 102 million yuan, and the management fee was 349,200 yuan.
Historical performance
| product name | typeTenure | tenure return | is average | Industry rankingProfit | andloss amount (yuan) | Management fee (yuan) | |
|---|---|---|---|---|---|---|---|
| ChinaAMC CSI Hong Kong Stock Connect Central Enterprises Dividend ETF | Equity Fund | 20240207 - to | date33.56% | 24.61% | 816/3434 | 104 million (2024) | 1,903,900 (2024) |
| ChinaAMC ChiNext Momentum Growth ETF Initiator Feeder A | Equity Fund | 20220610 - | Present-28.37% | -3.96% | 2245/2549 | - 446 million (2022H2 - 2024H2) | 849,600 (2022H2 - 2024H2) |
| ChinaAMC CSI All-Index Securities Company ETF Linked A | Equity Fund | 20220610 - | 14.47% | - -3.96% | to date414/2549 | 102 million (2022H2 - 2024H2) | 349,200 (2022H2 - 2024H2) |
| ChinaAMC Strategic Emerging Component Index ETF | Equity Fund | 20230327 - | Present-14.15% | - 1.94% | 2214/ | 2920-27.2205million (2023H2 - 2024H2) | 1.6508 million (2023H2 - 2024H2) |
| ChinaAMC CSI Zhejiang State-owned Assets Innovation and Development ETF | Equity Fund | 20230327 - Present | 16.08% | -1.94% | 366/2920 | 17.243 million (2023H2 - 2024H2) | 1.3996 million (2023H2 - 2024H2) |
| ChinaAMC CSI Hong Kong Stock Connect Central Enterprises Dividend ETF Initiator Connection A | Equity Fund | 20240416 - | Present22.90% | 19.10% | 1150/3565 | 21,614,900 (2024) | 31,300 (2024) |
| ChinaAMC CSI 2000 ETF | Equity funds | 20230906 - to date | : 24.24%, | 4.78%, | 225/3147 | ,25.6839 million (2023H2 - 2024H2), | 848,300 (2023H2 - 2024H2 |
| ). ChinaAMC CSI Agriculture Theme ETF | Equity Fund | 20240531 - - | 6.93% | 15.28% | 3527/3688 | 1,923,200 (2024H2) | 334,000 (2024H2 |
| ). ChinaAMC Strategic Emerging Component Index ETF Linked A | Equity Fund | 20230327 - | Present-13.37% | -1.94% | 2179/2920-23,028,000 | (2023H2 - 2024H2) | 76,300( 2023H2 - 2024H2) |
| ChinaAMC CSI All-Index Information Technology ETF | Equity Fund | 20240327 - to | date35.09% | 17.60% | 352/3524 | 5,971,200 (2024) | 257,600 (2024) |
| ChinaAMC CSI Zhejiang State-owned Assets Innovation and Development ETF Linked A | Equity Fund | 20230327 - | 15.09% | -1.94% | todate387/2920 | 3.3239 million (2023H2 - 2024H2). | 18,600 (2023H2 - 2024H2) |
| ChinaAMC CSI All-Index Optional Consumer ETF | Equity Fund | 20240318 - | Present21.59% | 12.02% | 600/3487 | 6,525,700 (2024) | 168,000 (2024) |
| ChinaAMC CSI 2000 ETF Initiation Linked A | Equity Fund | 20231108 - | 11.20% | 8.49% | 1158/3251 | 13.2034 million (2023H2 - 2024H2) | 15,500 (2023H2 - 2024H2) |
| ChinaAMC CSI All-Index Information Technology ETF Initiator Feeder A | Equity Fund | 20241015 - to | date7.18% | 7.37% | 1543/3953 | 1,500,900 (2024H2) | 5283.24 (2024H2) |
| ChinaAMC CNI Vaccine and Biotechnology Index Initiator A | Equity Fund | 20220906 - - | 35.08% | -2.73% | to date2472/ | 2665-49,163,900 (2022H2 - 2024H2) | 1,172,900 (2022H2 - 2024H2) |
| ChinaAMC CSI Agriculture Theme ETF Initiator Feeder A | Equity Fund | 20220819 - - | 29.38% to date | -5.33% | 2293/2654-8,856,800 | (2022H2 - 2024H2) | 19,200 (2022H2 - 2024H2) |
| ChinaAMC CSI All-Index Optional Consumer ETF Initiation Feeder A | Equity Fund | 20240606 - | Present17.53% | 15.90% | 1332/3705 | 1,565,500 (2024) | 3403.53 (2024) |
| ChinaAMC CSI Internet of Things Theme ETF Initiation Connection A | Equity Fund | 20231110 - to date | : 17.90%, | 9.29%, | 670/3258 | ,1.653 million , (2023H2 - 2024H2), | 2944.36 (2023H2 - 2024H2). |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date
